Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor-Associated Retinopathy.
Sign Up to like & getrecommendations! Published in 2021 at "JAMA ophthalmology"
DOI: 10.1001/jamaophthalmol.2021.3331
Abstract: Importance Fibroblast growth factor receptor (FGFR) 1 to 4 inhibitors are approved by the US Food and Drug Administration and suppress the mitogen-activated protein kinase (MAPK) pathway, with a potential for treatment-related retinopathy. To date,… read more here.
Keywords: iqr; inhibitor associated; fluid; fgfr inhibitors ... See more keywords
Targeting the cancer cells and cancer‐associated fibroblasts with next‐generation FGFR inhibitors in prostate cancer co‐culture models
Sign Up to like & getrecommendations! Published in 2024 at "Cancer Medicine"
DOI: 10.1002/cam4.70240
Abstract: Inhibition of androgen receptor (AR) signaling is the main treatment strategy in advanced prostate cancer (PCa). A subset of castration resistant prostate cancer (CRPC) bypasses the AR blockade by increased fibroblast growth factor receptor (FGFR)… read more here.
Keywords: cancer; fgfr inhibitors; generation; prostate cancer ... See more keywords
Targeting FGFR inhibition in cholangiocarcinoma.
Sign Up to like & getrecommendations! Published in 2021 at "Cancer treatment reviews"
DOI: 10.1016/j.ctrv.2021.102170
Abstract: Cholangiocarcinomas (CCAs) are rare but aggressive tumours of the bile ducts, which are often diagnosed at an advanced stage and have poor outcomes on systemic therapy. Somatic alterations with therapeutic implications have been identified in… read more here.
Keywords: targeting fgfr; inhibition; inhibition cholangiocarcinoma; fgfr inhibitors ... See more keywords
Identification of Pyridinyltriazine Derivatives as Potent panFGFR Inhibitors against Gatekeeper Mutants for Overcoming Drug Resistance.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.1c01776
Abstract: Although FGFR inhibitors hold promise in treating various cancers, resistance to the FGFR inhibitors caused by acquired secondary mutations has emerged. To discover novel FGFR inhibitors capable of inhibiting FGFR mutations, including gatekeeper mutations, we… read more here.
Keywords: fgfr inhibitors; pyridinyltriazine derivatives; identification pyridinyltriazine; potent panfgfr ... See more keywords
Discovery of 2-Amino-7-sulfonyl-7H-pyrrolo[2,3-d]pyrimidine Derivatives as Potent Reversible FGFR Inhibitors with Gatekeeper Mutation Tolerance: Design, Synthesis, and Biological Evaluation.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.2c01420
Abstract: Fibroblast growth factor receptors (FGFRs) play key roles in promoting cancer cell proliferation, differentiation, and migration. However, acquired resistance to FGFR inhibitors has become an emerging challenge in long-term cancer therapies, especially for hepatocellular carcinoma… read more here.
Keywords: sulfonyl pyrrolo; amino sulfonyl; fgfr inhibitors; pyrrolo pyrimidine ... See more keywords
Discovery of Potent Irreversible Pan-Fibroblast Growth Factor Receptor (FGFR) Inhibitors.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.7b01843
Abstract: Fibroblast growth factor receptors (FGFR1-4) are promising therapeutic targets in many cancers. With the resurgence of interest in irreversible inhibitors, efforts have been directed to the discovery of irreversible FGFR inhibitors. Currently, several selective irreversible… read more here.
Keywords: growth factor; growth; fibroblast growth; fgfr inhibitors ... See more keywords
BIOM-79. TARGETING FGFR ALTERATIONS IN GLIOMAS: A SINGLE-INSTITUTION CASE SERIES
Sign Up to like & getrecommendations! Published in 2025 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noaf201.0167
Abstract: Fibroblast growth factor receptor (FGFR) alterations are a potentially actionable target in various cancers, including glioblastoma (GBM). FGFR inhibitors have shown variable efficacy in GBM to date. We present a single-institution experience utilizing FGFR inhibitors… read more here.
Keywords: fgfr alterations; fgfr inhibitors; single institution; fusion ... See more keywords
Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion Cholangiocarcinoma
Sign Up to like & getrecommendations! Published in 2020 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1535-7163.mct-19-0631
Abstract: The fibroblast growth factor receptor (FGFR) signaling pathway is aberrantly activated in approximately 15% to 20% of patients with intrahepatic cholangiocarcinoma. Currently, several FGFR kinase inhibitors are being assessed in clinical trials for patients with… read more here.
Keywords: cholangiocarcinoma; combination; resistance; fgfr inhibitors ... See more keywords
Abstract 3395: Clinical impact of FGFR inhibitors on FGFR2 positive pancreatic cancer
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-3395
Abstract: Objectives: Here we describe the durable clinical outcomes of four FGFR2 fusion positive pancreatic cancer patients treated with FGFR inhibitors as well as a pancreatic specific analysis of FGFR alterations through our collaboration with Foundation… read more here.
Keywords: cancer; fusion; pancreatic cancer; fgfr inhibitors ... See more keywords
Abstract 1746: FGFR3 inhibition is a highly effective therapy in MTAP-deficient, FGFR3 altered urothelial carcinoma
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Research"
DOI: 10.1158/1538-7445.am2025-1746
Abstract: FGFR3 alterations are observed in more than 15% of metastatic urothelial cancers. In 2019, erdafitinib was the first FGFR inhibitor approved by the FDA for treatment of FGFR3-altered metastatic urothelial cancer with an objective response… read more here.
Keywords: mtap deficient; fgfr inhibitors; fgfr3 altered;
Fibroblast growth factor receptor (FGFR) inhibitors: A review of a novel therapeutic class
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155220983425
Abstract: Comprehensive genomic profiling has an emerging role in cancer therapeutics. As treatment options remain needed for advanced cancers, patients are relying increasingly more on tumor genomic alterations as possible targets for cancer treatment. Frequent tumor… read more here.
Keywords: receptor fgfr; fibroblast growth; fgfr inhibitors; growth factor ... See more keywords